<DOC>
	<DOC>NCT01346046</DOC>
	<brief_summary>The primary objective of the trial is to collect SCOUT DS and Hemoglobin A1c measurements of subjects who have been diagnosed with Type 2 diabetes.</brief_summary>
	<brief_title>Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2</brief_title>
	<detailed_description>Previous studies have excluded subjects with Type 2 diabetes. The primary objective of this study is to correct an imbalance in the disease prevalence of the data set used to develop the SCOUT DS diabetes screening algorithm.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Age greater than or equal to 18 years Selfreported diagnosis of type 2 diabetes No Selfreported diagnosis of type 2 diabetes Less than 18 years of age Diagnosed with type 1 diabetes Known to be pregnant (Self Reported) Receiving dialysis or having known renal compromise Scars, tattoos, rashes or other disruption/discoloration on the left volar forearm. Known to have, or at risk for, photosensitivity reactions ( e.g., sensitive to ultraviolet light, or taking medication known to cause photosensitivity)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Adults 18 years and older</keyword>
	<keyword>Taking Control of Your Diabetes Health Fair</keyword>
</DOC>